Physician profile
Thomas A Brown
NPI 1053402263
$550.98
in general payments reported to CMS, 2019-2025
8 companies · $44.42 in 2025
The $44.42 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $115 · 2022: $201 · 2023: $135 · 2024: $56.24 · 2025: $44.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $138.60 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $134.94 | 2023 | |
| Quidel Corporation | $114.50 | 2021 | |
| Axsome Therapeutics, INC. | $92.08 | 2022-2024 | Auvelity |
| Aimmune Therapeutics, INC. | $23.28 | 2025 | Vowst |
| Abbvie INC. | $21.14 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $18.78 | 2022 | |
| Corium, LLC | $7.66 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.